节点文献

p80蛋白在间变性大细胞淋巴瘤中的表达意义

The expression of p80 protein in anaplastic large cell lymphoma

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 钟森朱润庆柯尊富杜兴贵张丽

【Author】 ZHONG Sen~1 , ZHU Run-Qing~1 , KE Zun-Fu~1 , et al (1Department of Pathology,Medical College in Wuhan University,Hubei 430071;2Department of Pathology, Yunyang Medical College;3Department of pathology, RenMin Hospital,Shiyan, Hubei 442000)

【机构】 武汉大学医学院病理学教研室郧阳医学院病理学教研室郧阳医学院附属人民医院病理科 湖北武汉430071湖北武汉430071湖北武汉430071

【摘要】 目的探讨p80蛋白在间变性大细胞淋巴瘤(ALCL)中的表达及与预后的关系。方法用SP法检测CD30、CD20、CD45RO和p80在28例ALCL中的表达情况。结果CD30全部呈强阳性表达,p80蛋白有13例呈强阳性,p80蛋白阳性病例的免疫学表型为T细胞性11例和Null细胞性2例,无B细胞性和T、B细胞标记均表达的病例(P<0.05)。p80蛋白与ALCL的发病年龄、AnnArbor分期均无关,而与5年生存率密切相关(P<0.01)。结论CD30和p80蛋白的检测可用于ALCL的诊断、鉴别诊断及预后的判断。

【Abstract】 Objective To study the expression of p80 in anaplastic large cell lymphoma (ALCL) and its relationship with ALCL’s prognosis.Methods Immunohistochemical staining were performed in twenty-eight cases of ALCL by using monoclonal antibody p80~NPM/ALK and CD20,CD30 and CD45RO.Results All 28 case of ALCLs revealed strongly CD30 positive;p80 were also expressed in 13 cases,in which 11 cases with T cell and 2 with Null cell respectively. p80 expression was not correlated with ALCL’s age and AnnArbo stages,but its 5-year-survival rate(P<0.01).Conclusions The CD30 and P80 might be an useful marker for diagnosis and prognosis judgement of ALCL.

【关键词】 淋巴瘤p80蛋白预后免疫组织化学
【Key words】 lymphomap80 proteinprognosisimmunohistochemistry
  • 【文献出处】 郧阳医学院学报 ,Journal of Yunyang Medical College , 编辑部邮箱 ,2004年06期
  • 【分类号】R733.1
  • 【被引频次】2
  • 【下载频次】26
节点文献中: 

本文链接的文献网络图示:

本文的引文网络